Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. EyePoint Pharmaceuticals Inc shares valued at $329,817 were purchased by David R. Guyer on Oct 14 ’24. At $8.92 per share, David R. Guyer acquired 36,975 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, DICICCO WENDY F purchased 2,567 shares, netting a total of over 19,997 in proceeds. Following the buying of shares at $7.79 each, the insider now holds 9,967 shares.
Before that, ANDO GORAN had added 5,000 shares to its account. In a trade valued at $39,750, the Director bought EyePoint Pharmaceuticals Inc shares for $7.95 each. Upon closing the transaction, the insider’s holdings increased to 5,000 shares, worth approximately $0.15 million.
As published in their initiating research note from Scotiabank on October 16, 2024, EyePoint Pharmaceuticals Inc [EYPT] has been a Sector outperform. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in late August. As of January 22, 2024, JP Morgan has initiated its “an Overweight” rating for EYPT. Earlier on November 02, 2023, Mizuho initiated its rating. Their recommendation was “a Buy” for EYPT stock.
Analyzing EYPT Stock Performance
During the last five days, there has been a surge of approximately 34.45%. Over the course of the year, EyePoint Pharmaceuticals Inc shares have dropped approximately -51.19%. Shares of the company reached a 52-week high of $30.99 on 02/08/24 and a 52-week low of $7.40 on 08/14/24. A 50-day SMA is recorded $8.60, while a 200-day SMA reached $15.30. Nevertheless, trading volume fell to 1.11 million shares from 0.82 million shares the previous day.
Support And Resistance Levels for EyePoint Pharmaceuticals Inc (EYPT)
According to the 24-hour chart, there is a support level at 10.34, which, if violated, would cause prices to drop to 9.39. In the upper region, resistance lies at 11.80. The next price resistance is at 12.31. RSI (Relative Strength Index) is 74.16 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.65, which suggests the price will increase in the coming days. Percent R is at 2.51%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
